This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Punit Upadhyaya, PhD
Senior Principal Scientist, Quantitative Pharmacology at Bicycle Therapeutics


Punit Upadhyaya is a Senior Principal Scientist in the quantitative pharmacology group at Bicycle Therapeutics, a company dedicated to developing small, synthetic bicyclic peptides (Bicycles®) as transformative medicines. Prior to joining Bicycle therapeutics, he worked at Ra Pharmaceuticals (acquired by UCB) developing macrocyclic peptides against targets in the complement pathway. Punit received his Ph.D. from The Ohio State University.

Agenda Sessions

  • Chairman’s Remarks: Peptide-Drug Conjugates as Tumor Targeted Therapies

  • Discovery of BT7480: Optimization of the Potency, Pharmacokinetics and Physiochemical Properties of a Synthetic Bicyclic Peptide Based Nectin-4-targeted CD137 Agonist for the Treatment of Solid Tumors